Skip to main content

Table 3 Metabolic parameters and lipid profile at baseline and at 12 months

From: Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children

PATIENT CHOLESTEROL HDL-cho LDL-cho TG GLUCOSE INSULIN C-PEPTIDE
  (mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl) (IU/ml) (ng/ml)
  Values 0–12 m 0–12 m 0–12 m 0–12 m 0–12 m 0–12 m 0–12 m
1 250–182 40–47 179–127 155–36 99–97 8,9–8,4 1,1–1,6
2 192–200 NA – 65 NA – 126 70–41 91–84 4,8–5,2 0,8–1,93
3 338–245 63–69 112–160 112–59 86–94 4,6-NA 0,74-NA
4 325–290 56–61 250–193 92–177 85–86 9,6–8,9 1,8-NA
5 188–152 32–48 133–93 116–92 88–88 9,8–19,4 0,5–0,4
6 120–101 37–35 71–60 60–29 75–78 10–12,3 2,2–1,3
7 195–220 45–52 126–150 118–86 81–85 10–6,9 1,1–1,4
median at baseline 195(120,338) 45(32,63) 129(71,250) 74(60,92) 86(75,99) 9,6(4,6–10) 1,3(0,5–2,5)
median at 12 m 200(101,290) 52(35,69) 127(60,193) 74(29,177) 87(78,97) 8,6(5,2–19,9) 1,4(0,4–1,93
P 0,09 0,04 0,34 0,17 0,4 0,9 0,9
  1. Evolution after switching.
  2. HDL-cho: HDL-cholesterol, LDL-cho: LDL-cholesterol, TG: triglycerides
  3. To convert cholesterol from mg/dl to mmol/l, multiply by 0.0259
  4. To convert triglycerides from mg/dl to mmol/l, multiply by 0.0113
  5. To convert insulin from IU/ml to pmol/l, multiply by 7.175
  6. To convert C-peptide from ng/ml to nmol/l, multiply by 0.33
  7. To convert glucose from mg/dl to mmol/l, multiply by 0.0555